Skip to content
Wearables & measurementCohort study3 min read

10 older adults wore a sensor: steps and walking fell in the pandemic, depression rose

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Decrease in Mobility during the COVID-19 Pandemic and Its Association with Increase in Depression among Older Adults: A Longitudinal Remote Mobility Monitoring Using a Wearable Sensor. · Sensors (Basel, Switzerland) · 2021 · Original paper ↗

Key takeaway

In 10 community-dwelling older adults, step counts fell by 55.1% and walking time by 52.2% after the pandemic declaration, while depression symptoms rose by 150%. With only 10 people and no comparison group, these are descriptive changes, not proof that reduced movement caused the depression.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Social isolation during COVID-19 may harm older adults' wellbeing. The authors measured how physical activity and sleep changed from before to after the pandemic declaration, and whether those changes tracked with depression.

Who and how

Longitudinal observational study of 10 older adults (age 77.3 ± 1.9 years, 40% female). A pendant wearable system remotely measured physical activity and sleep from 3 months before to 6 months after the pandemic declaration. Depression was assessed before and after with the Center for Epidemiologic Studies Depression scale and compared with 48 h of continuous activity monitoring before and during the pandemic.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    After the declaration, time standing fell by 32.7% (Cohen's d = 0.78, p < 0.01), walking by 52.2% (d = 1.1, p < 0.01), step counts by 55.1% (d = 1.0, p = 0.016) and postural transitions by 44.6% (d = 0.82, p = 0.017).
  2. 2
    Sitting time rose by 20.5% (d = 0.5, p = 0.049), and depression symptoms increased by 150% (d = 0.8, p = 0.046).
  3. 3
    Greater increases in depression correlated with unbroken prolonged sitting bouts (rho = 0.677, p = 0.032), cadence (rho = -0.70, p = 0.024) and sleep duration (rho = -0.72, p = 0.019).

Limits & uncertainty

  1. 1
    Only 10 participants, so estimates are imprecise and the borderline p-values are fragile, especially with multiple outcomes and correlations tested.
  2. 2
    There is no comparison group, so changes cannot be separated from other effects over time such as season or ageing.
  3. 3
    Correlations show association; the abstract does not support saying reduced activity caused depression, and a larger percentage rise in a small baseline score can look big.
  4. 4
    Activity was compared using 48 h windows, which may not represent typical weeks. This reading is based on the abstract only.

What to take from it

The pattern fits the idea that restricted movement and mood can decline together in older adults, but 10 people are far too few to draw firm conclusions. If someone notices lasting low mood or a sharp fall in activity, it is worth raising with a clinician.

Reading your own data

Daily steps, long unbroken sitting periods and sleep duration are exactly the kind of data wearables record. Compare your own weeks with the same device and wear pattern, and watch for sustained drops rather than one quiet day.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Social isolation during COVID-19 may negatively impact older adults' wellbeing. To assess its impact, we measured changes in physical activity and sleep among community-dwelling older adults, from pre-to post-pandemic declaration.

Method

Physical activity and sleep in older adults (n = 10, age = 77.3 ± 1.9 years, female = 40%) were remotely assessed within 3-month pre-to 6-month post-pandemic declaration using a pendant-wearable system. Depression was assessed pre-and post-pandemic declaration using the Center for Epidemiologic Studies Depression scale and was compared with 48 h continuous physical activity monitoring data before and during pandemic.

Results

Compared to pre-pandemic, post-pandemic time spent in standing declined by 32.7% (Cohen's d = 0.78, p < 0.01), walking by 52.2% (d = 1.1, p < 0.01), step-counts by 55.1% (d = 1.0, p = 0.016), and postural transitions by 44.6% (d = 0.82, p = 0.017) with increase in sitting duration by 20.5% (d = 0.5, p = 0.049). Depression symptoms increased by 150% (d = 0.8, p = 0.046). Interestingly, increase in depression was significantly correlated with unbroken-prolong sitting bout (ρ = 0.677, p = 0.032), cadence (ρ = -0.70, p = 0.024), and sleep duration (ρ = -0.72, p = 0.019).

Conclusion

This is one of the early longitudinal studies highlighting adverse effect of the pandemic on objectively assessed physical activity and sleep in older adults. Our observations showed need for timely intervention to mitigate hard to reverse consequences of decreased physical activity such as depression.

Sources & attribution

Decrease in Mobility during the COVID-19 Pandemic and Its Association with Increase in Depression among Older Adults: A Longitudinal Remote Mobility Monitoring Using a Wearable Sensor.

Mishra R, Park C, York MK, Kunik ME, Wung SF, Naik AD, Najafi B.

Sensors (Basel, Switzerland) · 2021-04-29

DOI: 10.3390/s21093090 ↗PubMed · 33946664 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →